CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • New Clinical Trials to Offer Immunotherapy as Frontline Treatment for Lung Cancer

    Patients with lung cancer will soon be able to receive immunotherapy as first-line treatment on an experimental…

    July 7, 2015| Matthew Tontonoz
  • When Is a Spot Not a Spot?

    A ten-year effort to optimize a ubiquitous laboratory assay finally pays off.

    July 2, 2015| Matthew Tontonoz
  • Immunotherapy: 5 Ways to Stop Cancer

    The Cancer Research Institute has created a series of short, animated videos that explain the basics of…

    June 26, 2015| Matthew Tontonoz
  • ASCO 2015: Report from Day 5

    The last day of the ASCO meeting featured talks on immunotherapy for pancreatic cancer, one the deadliest…

    June 2, 2015| Matthew Tontonoz
  • ASCO 2015: Report from Day 4

    More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.

    June 1, 2015| Matthew Tontonoz
  • ASCO 2015: Report from Day 3

    Immunotherapy for brain cancer and the results of a large clinical trial for patients with advanced melanoma.

    May 31, 2015| Matthew Tontonoz
  • ASCO 2015: Report from Day 2

    The latest results from clinical trials of checkpoint inhibitors for lung cancer, liver cancer, and more.

    May 30, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 5

    Some lesser-known cell types in the immune response to cancer were discussed on the meeting's final day.

    April 22, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 4

    Spotlight on CAR T cell therapy.

    April 21, 2015| Matthew Tontonoz

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute